Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 NIH To Fund Study On Tocotrienol's Effects On Neuro-Degenerative Diseases - Nutraceuticals World
Market Updates

NIH To Fund Study On Tocotrienol’s Effects On Neuro-Degenerative Diseases

NIH To Fund Study On Tocotrienol’s Effects On Neuro-Degenerative Diseases
The National Institutes of Neurological Disorders and Stroke of the National Institute of Health (NIH) has awarded in excess of $1 million to investigate how a member of the vitamin E family—alpha-tocotrienol—helps protect against inducible neuronal cell death. This is the first-ever NIH-funded study on alpha-tocotrienol, the palm-derived form of vitamin E. The award is based on preliminary data generated using Edison, NJ-based Carotech’s Tocomin® Full Spectrum Tocotrienol Complex. Previous research on Tocomin® has determined that tocotrienols cross the blood-brain barrier, and are potent protectors of neuron cells that may be killed due to stroke and other neurodegenerative diseases. The NIH-funded study will look at the mechanism by which alpha-tocotrienol exerts its neuroprotective action. It will lay the foundation for a safe and efficient approach to preventing cell death and securing normal neural function under challenging conditions.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters